Sep 18 |
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices
|
Sep 6 |
Elutia Celebrates First Year
|
Aug 20 |
Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
|
Aug 10 |
Elutia Inc. 2024 Q2 - Results - Earnings Call Presentation
|
Aug 10 |
Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript
|
Aug 7 |
Elutia GAAP EPS of -$1.14 misses by $0.81, revenue of $6.3M misses by $0.35M
|
Aug 7 |
Elutia Announces Second Quarter 2024 Results
|
Aug 1 |
Elutia reports full exercise of warrants generating $15.7M in gross proceeds
|
Aug 1 |
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
|
Jul 31 |
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
|